Data compiled by Redley Lamar · ChainSifter Intelligence
0Suppliers
4Customers
3Debt Items
12Related Chains
Source-Backed Evidence Depth
Bolt Biotherapeutics, Inc. (BOLT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
8Total relationships
2Distinct source URLs
8High confidence
0.896Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Bolt Biotherapeutics, Inc. Suppliers
No suppliers on recordBolt Biotherapeutics, Inc. does not appear to disclose named supplier relationships in its verified regulatory filings, or upstream suppliers have not yet been identified. Our system processes new filings continuously.
Bolt Biotherapeutics, Inc. Customers
Ticker
Name
Confidence
Evidence
GNMSF
Genmab A/S
92%
Reciprocal relationship from GNMSF graph: Reciprocal relationship from BOLT graph: Reciprocal relationship from GNMSF graph: Reciprocal relationship from BOLT graph: Reciprocal relationship from GNMS…
GENMAB
GENMAB
90%
The Company determined that the Genmab Agreement is a contract with a customer and should be accounted for under ASC 606.
TORAY-INDUSTRIES-INC
TORAY-INDUSTRIES-INC
90%
The Company determined that the Toray Agreement is a contract with a customer and should be accounted for under ASC 606.
GNMSF
Genmab A/S
85%
s covered under the agreement as a whole. Such optional additional items will be accounted for as contract modifications when development advances past certain milestones and the parties both exercis…
Bolt Biotherapeutics, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
BOLT-DEBT-8324
Warrants outstanding: 0.07
90%
xbrl warrant detail from xbrl 2018-07-31.
BOLT-DEBT-8325
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2021-12-31.
BOLT-DEBT
Debt stack $22.3M
90%
Market cache reports total debt of $22.3M.
Bolt Biotherapeutics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Bolt Biotherapeutics, Inc..
Bolt Biotherapeutics, Inc. Ownership
Holder
Name
Confidence
Evidence
BOLT-OWNER-VIVO-CAPITAL-LLC
Vivo Capital, LLC
90%
13F overlay lists Vivo Capital, LLC as top holder; 24 tracked holders.
Bolt Biotherapeutics, Inc. Extended Supply Chain Network
